← Legislation / NS359
NS359INTRODUCEDHEALTHNOVA SCOTIA
Fair Drug Pricing Act (amended)
Long title not yet sourced from the legislative registry.
- Sponsor
- —
- Introduced
- —
- Royal assent
- —
- Final vote
- —
Legislative timeline
- 1st—
- 2nd—
- Comm.—
- 3rd—
- Senate—
- Assent—
Bill overview
Bill NS359, “Fair Drug Pricing Act (amended)”, is a Nova Scotia bill from session assembly-64-session-1.
Its latest recorded status is “Introduced”.
This overview is written automatically from the registry and vote records on this page and updates when they sync. It describes the bill's path, not its merits.
PLAIN-LANGUAGE SUMMARY
What you need to know
Status changed: 2023-10-19T00:00:00.000
Key provisions
- 01This Act amends the Fair Drug Pricing Act to require pharmaceutical companies to disclose their pricing strategies.
- 02The Minister of Health is responsible for developing and implementing a framework for monitoring and enforcing compliance with the Act.
- 03Pharmaceutical companies must submit annual reports to the Minister detailing their pricing decisions and revenue projections.
- 04The Minister may conduct audits to verify the accuracy of the reports submitted by pharmaceutical companies.
- 05The Act establishes a penalty system for non-compliance, including fines and potential revocation of licenses.
Vote roll
No division has been recorded for this bill yet.